FIELD: medicine, immunology, pharmacology. SUBSTANCE: invention proposes the use of para-aminobenzoic acid as an interferon inducing agent. Invention can be used for treatment of patients with different sicknesses associated with the impaired interferon synthesis in the organism. This disorder is the main cause of development of different pathologies of an organism, for example, viral diseases (herpes simplex virus, cytomegalovirus, human immunodeficiency virus, adenovirus and others), neoplasms, ulcers, inflammatory processes of the different genesis and others. EFFECT: broadened formulations of the interferon inducing agents. 4 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2116070C1 |
| AGENT FOR TREATMENT OF VIRAL DISEASES CAUSED BY HERPES VIRUS | 1993 |
|
RU2068691C1 |
| METHOD AND MEANS FOR STIMULATING RESISTANCE TO INFECTION | 2001 |
|
RU2191594C1 |
| SUPPOSITORIES AND METHOD OF PROPHYLAXIS AND TREATMENT OF DISEASES TRANSMITTED BY GENITAL TRACTS | 1999 |
|
RU2147873C1 |
| SUCKING PILL CONTAINING HUMAN INTERFERON AND/OR INTERFERON INDUCTOR POSSESSING ANTIVIRAL ACTIVITY | 2004 |
|
RU2277932C2 |
| ANTICOAGULATION DRUG | 1996 |
|
RU2146138C1 |
| METHOD FOR DRY EYE SYNDROME TREATMENT IN PATIENTS WITH DIABETES MELLITUS | 2020 |
|
RU2749984C1 |
| METHODS OF PREVENTION AND TREATMENT OF DISEASES CAUSED BY A/H5N1 BIRD INFLUENZA VIRUS WITH USING INTERFERON INDUCER AND NEURAMINIDASE INHIBITOR | 2008 |
|
RU2398596C2 |
| INTERFERON INDUCTOR | 2004 |
|
RU2252775C1 |
| METHOD FOR ENDOGENOUS INTERFERON INDUCTION | 2010 |
|
RU2427373C1 |
